4.6 Review

Advanced Morphologic Analysis for Diagnosing Allograft Rejection: The Case of Cardiac Transplant Rejection

期刊

TRANSPLANTATION
卷 102, 期 8, 页码 1230-1239

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TP.0000000000002189

关键词

-

资金

  1. National Center for Advancing Translational Sciences of the National Institutes of Health [TL1TR001880]
  2. National Cancer Institute of the National Institutes of Health [R21CA179327-01, R21CA195152-0, U24CA199374-01]
  3. National Institute of Diabetes and Digestive and Kidney Diseases [R01DK098503-02]
  4. National Heart Lung and Blood Institute [R01-HL105993]
  5. DOD Prostate Cancer Synergistic Idea Development Award [PC120857]
  6. DOD Lung Cancer Idea Development New Investigator Award [LC130463]
  7. DOD Prostate Cancer Idea Development Award
  8. Case Comprehensive Cancer Center Pilot Grant
  9. VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University
  10. I-Corps@Ohio Program
  11. Philips Healthcare
  12. NIH
  13. PathCore Inc.
  14. Inspirata
  15. Thoratec Corporation
  16. Merck
  17. Glaxo-Smith-Kline
  18. NATIONAL CANCER INSTITUTE [R21CA179327, R01CA208236, U24CA199374, R21CA195152, R01CA216579, R01CA202752] Funding Source: NIH RePORTER
  19. NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001880] Funding Source: NIH RePORTER
  20. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105993, R01HL089847] Funding Source: NIH RePORTER
  21. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098503] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Allograft rejection remains a significant concern after all solid organ transplants. Although qualitative morphologic analysis with histologic grading of biopsy samples is the main tool employed for diagnosing allograft rejection, this standard has significant limitations in precision and accuracy that affect patient care. The use of endomyocardial biopsy to diagnose cardiac allograft rejection illustrates the significant shortcomings of current approaches for diagnosing allograft rejection. Despite disappointing interobserver variability, concerns about discordance with clinical trajectories, attempts at revising the histologic criteria and efforts to establish new diagnostic tools with imaging and gene expression profiling, no method has yet supplanted endomyocardial biopsy as the diagnostic gold standard. In this context, automated approaches to complex data analysis problemsoften referred to as machine learningrepresent promising strategies to improve overall diagnostic accuracy. By focusing on cardiac allograft rejection, where tissue sampling is relatively frequent, this review highlights the limitations of the current approach to diagnosing allograft rejection, introduces the basic methodology behind machine learning and automated image feature detection, and highlights the initial successes of these approaches within cardiovascular medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据